NCT04206553 - A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid | Biotech Hunter

Enrollment

106

Participants

Timeline

Start Date

October 28, 2020

Primary Completion Date

July 12, 2024

Study Completion Date

January 5, 2025

Conditions

Bullous Pemphigoid

Interventions

DRUG

dupilumab

Loading dose administered subcutaneous (SC), followed by SC once every 2 weeks (Q2W) dosing.

DRUG

Matching Placebo

Matching dupilumab without active substance

DRUG

Oral corticosteroids (OCS)

Prednisone or prednisolone per standard of care to obtain control of disease activity.

Trial Locations (53)

2217

Regeneron Study Site, Kogarah

3128

Regeneron Study Site, Box Hill

10002

Regeneron study Site, Taipei

10117

Regeneron Study Site, Berlin

19104

Regeneron Study Site, Philadelphia

21614

Regeneron Study Site, Buxtehude

22903

Regeneron study Site, Charlottesville

23538

Regeneron Study Site, Lübeck

27516

Regeneron Study Site, Chapel Hill

28034

Regeneron Study Site, Madrid

28046

Regeneron study Site, Madrid

31008

Regeneron study Site, Pamplona

32827

Regeneron study Site, Orlando

33000

Regeneron Study Site, Bordeaux

33125

Regeneron Study Site, Miami

33305

Regeneron study Site, Taoyuan

35043

Regeneron Study site, Marburg

35233

Regeneron study Site, Birmingham

39120

Regeneron Study site', Magdeburg

48149

Regeneron Study Site, Münster

49100

Regeneron study Site, Petah Tikva

50566

Regeneron Study site', Wroclaw

52242

Regeneron Study Site, Iowa City

55131

Regeneron Study Site, Mainz

59037

Regeneron Study Site, Lille

70178

Regeneron Study Site, Stuttgart

75010

Regeneron Study Site, Paris

76031

Regeneron Study Site, Rouen

79104

Regeneron Study Site, Freiburg im Breisgau

80802

Regeneron Study Site, Munich

84107

Regeneron Study Site, Murray

85259

Regeneron Study Site, Scottsdale

91054

Regeneron Study Site, Erlangen

93009

Regeneron Study Site, Bobigny

94063

Regeneron Study Site, Redwood City

97239

Regeneron Study Site, Portland

1834111

Regeneron study Site, Afula

6423906

Regeneron study Site, Tel Aviv

06030

Regeneron Study Site, Farmington

02116

Regeneron Study Site, Boston

48109-5314

Regeneron study Site, Ann Arbor

02908

Regeneron study Site, Providence

06200

Regeneron Study Site, Nice

01307

Regeneron Study Site 2, Dresden

830-0011

Regeneron Study site, Kurume

036-8563

Regeneron Study Site, Hirosaki

491-8558

Regeneron Study Site, Ichinomiya

545-8586

Regeneron Study Site, Osaka

060-8648

Regeneron Study Site, Sapporo

160-8582

Regeneron Study Site, Tokyo

31-147

Regeneron Study Site, Krakow

42-624

Regeneron Study site', Ossy

08916

Regeneron Study Site, Badalona